Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00558688 · ClinicalTrials.gov registry record · NA

A Photodynamic Therapy for Treatment of Actinic Keratoses

A NA study of Actinic Keratoses, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT00558688: Completed NA study of Actinic Keratoses, sponsored by Northwestern University.

NCT00558688 is a NA study of Actinic Keratoses that has completed, run by Northwestern University. The registered enrollment target is 20 participants, below the 96-participant average among 12 other Actinic Keratoses trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00558688, a NA study of Actinic Keratoses, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the efficacy of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light vs absence of treatment for actinic keratoses.

Conditions Studied

Interventions

  • PROCEDURE Photodynamic therapy

Study Locations (1)

Illinois

  • Northwestern University Department of Dermatology - Chicago

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2007-08
Est. Completion 2009-08
Phase NA
Northwestern University

1,209 total trials

What the finished NCT00558688 record still lists

NCT00558688 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 96-participant average among 12 other Actinic Keratoses trials with a reported enrollment target (79% lower).

The record links to 1 condition, with Actinic Keratoses appearing as the primary indexed condition, and to 1 intervention - of which Photodynamic therapy is the first listed.

NCT00558688 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT00558688 about?

NCT00558688 is a clinical study titled "A Photodynamic Therapy for Treatment of Actinic Keratoses". The purpose of this study is to compare the efficacy of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light vs absence of treatment for actinic keratoses.

What is the current status of trial NCT00558688?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2007-08. Estimated completion is 2009-08.

What conditions does trial NCT00558688 study?

This clinical trial studies the following conditions: Actinic Keratoses.

What interventions are being tested in trial NCT00558688?

The interventions under investigation include: Photodynamic therapy (PROCEDURE).

Who is sponsoring clinical trial NCT00558688?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00558688 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Actinic Keratoses

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00558688's enrollment target sits among peer trials

20 11th of 12 higher than 1 of 12 other Actinic Keratoses trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Actinic Keratoses trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00558688, the US trial registry maintained by the National Library of Medicine. NCT00558688 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.